AAMU
STDY

Amundi Asset Management US’s SteadyMed Ltd STDY Stock Holding History

Amundi Asset Management US’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-14,967
Closed -$67K – 1677
2018
Q2 		$67K Hold
14,967
– – ﹤0.01% 1491
2018
Q1 		$49K Buy
14,967
+1,200
+9% +$3.97K ﹤0.01% 1489
2017
Q4 		$51K Buy
+13,767
New +$44.5K ﹤0.01% 1492

Other funds holding STDY

AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Amundi Asset Management US's STDY Position: Q3 2018 in Review

Amundi Asset Management US sold out of SteadyMed Ltd (STDY) in Q3 2018, closing a stake of 14,967 shares — an estimated $67K sold.

Amundi Asset Management US first reported a position in STDY in Q4 2017 and held it in 3 quarters. The position peaked at $67K in Q2 2018. 5 funds tracked by Wall St. Rank hold STDY as of Q3 2018.

  • Amundi Asset Management US reported no remaining SteadyMed Ltd position as of Q3 2018 after selling out during the quarter.
  • Amundi Asset Management US sold 14,967 SteadyMed Ltd shares in Q3 2018, an estimated $67K.
  • Amundi Asset Management US first reported a position in SteadyMed Ltd in Q4 2017 and held it in 3 quarters.
  • Amundi Asset Management US's SteadyMed Ltd position peaked at $67K in Q2 2018.
  • 5 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q3 2018.

Based on Amundi Asset Management US's 13F filing for Q3 2018, filed 14 Nov 2018.